Anil Rajendra, MD
Clinical Cardiac Electrophysiology · Birmingham, ALNPI 1376740589
Payments from drug & device makers
Across 1,350 payments — averaging $1391.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$519K
- Boston Scientific$503K
- Biosense Webster, Inc.$303K
- Medical Device Business Services, Inc.$138K
- Cortex, Inc.$107K
- Abbott$85K
- plus $224K from 27 others
Across 1 payment — averaging $6575.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vektor Medical Inc.$7K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 139 | $518,896 |
| Boston Scientific | 357 | $502,738 |
| Biosense Webster, Inc. | 328 | $303,322 |
| Medical Device Business Services, Inc. | 74 | $138,254 |
| Cortex, Inc. | 1 | $107,154 |
| Abbott | 127 | $84,672 |
| Acutus Medical, Inc. | 120 | $70,809 |
| Philips North America LLC | 30 | $40,797 |
| Cardiofocus, Inc. | 4 | $24,876 |
| Impulse Dynamics (USA) Inc. | 24 | $22,890 |
| Cvrx, Inc. | 49 | $21,865 |
| Volta Medical Inc | 12 | $17,312 |
| Kardium Inc. | 4 | $14,000 |
| Sanofi-aventis U.S. LLC | 4 | $4,436 |
| Atricure, Inc. | 5 | $3,409 |
| Altathera Pharmaceuticals LLC | 3 | $1,142 |
| E.r. Squibb & Sons, L.L.C. | 11 | $450 |
| Johnson & Johnson(2 entities) | 10 | $331 |
| Vital Connect, Inc | 2 | $220 |
| Elutia, Inc. | 3 | $175 |
| Pfizer | 9 | $147 |
| Medicomp Inc | 1 | $137 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $126 |
| Amgen | 8 | $104 |
| Irhythm Technologies, Inc. | 4 | $70 |
| Akcea Therapeutics, Inc. | 4 | $62 |
| Novartis | 4 | $57 |
| Lantheus Medical Imaging, Inc. | 1 | $23 |
| Inari Medical, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
How this compares
$1,878,558 in reported general payments places this provider in the 95th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
See all clinical cardiac electrophysiology providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical cardiac electrophysiology in Birmingham
- Hugh McElderryBirmingham$1.9M
- Byron ColleyBirmingham$1.3M
- Gustavo MoralesBirmingham$638K
- William MaddoxBirmingham$615K
- Harish DoppalapudiBirmingham$104K
- Francis BennBirmingham$95K
- Terence DunnBirmingham$73K
- Ruchit ShahBirmingham$72K
- Ibrahim HannaBirmingham$59K
- Macy SmithBirmingham$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.